BRWA
TFFP

B. Riley Wealth Advisors’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

B. Riley Wealth Advisors’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,112
Closed -$113K – 1606
2022
Q3 		$113K Sell
1,112
-160
-13% -$21.6K ﹤0.01% 1308
2022
Q2 		$180K Hold
1,272
– – 0.01% 1053
2022
Q1 		$201K Hold
1,272
– – 0.01% 1217
2021
Q4 		$283K Buy
1,272
+200
+19% +$38.7K 0.01% 1108
2021
Q3 		$207K Buy
+1,072
New +$228K 0.01% 1235
2020
Q1 		– Sell
-540
Closed -$73K – 910
2019
Q4 		$73K Buy
+540
New +$69.3K 0.01% 804

Other funds holding TFFP

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
SC
Sepio Capital Salt Lake City, Utah $1.84B AUM 18.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

B. Riley Wealth Advisors's TFFP Position: Q4 2022 in Review

B. Riley Wealth Advisors sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2022, closing a stake of 1,112 shares — an estimated $113K sold.

B. Riley Wealth Advisors first reported a position in TFFP in Q4 2019 and held it in 6 quarters. The position peaked at $283K in Q4 2021. 41 funds tracked by Wall St. Rank hold TFFP as of Q4 2022.

  • B. Riley Wealth Advisors reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 1,112 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $113K.
  • B. Riley Wealth Advisors first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 6 quarters.
  • B. Riley Wealth Advisors's TFF Pharmaceuticals, Inc. Common Stock position peaked at $283K in Q4 2021.
  • 41 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on B. Riley Wealth Advisors's 13F filing for Q4 2022, filed 21 Feb 2023.